J and J Snack Foods Newswire

Comprehensive Real-Time News Feed for J and J Snack Foods.

Results 1 - 20 of 830 in J and J Snack Foods

  1. Why Medtronic Is One of the Smartest Companies on the PlanetRead the original story w/Photo

    17 hrs ago | The Motley Fool

    The report cited Medtronic's 2 gram pacemaker, the tiniest in the world, as its top example.

    Comment?

  2. Here Come Generics - Test Strips and a New All-In-One MeterRead the original story

    Thursday Apr 17 | Diabetes Mine

    It almost seems that a new era of alternative test strips and other "basic" diabetes products has hit.

    Comment?

  3. Johnson & Johnson's 3 Major StrengthsRead the original story

    Thursday Apr 17 | The Motley Fool

    Now seems like an opportune moment to check out the strengths of J&J as a group, with this article being the first of four that, in turn, will highlight the strengths, weaknesses, opportunities, and threats it is facing.

    Comment?

  4. J&J Q1 net up 8 percent on sales jump, lower costsRead the original story w/Photo

    Tuesday Apr 15 | Deseret News

    This Oct. 16 2012 photo shows Johnson and Johnson products, including Band Aid brand adhesive bandages, arranged for a photo in St. Petersburg, Fla.

    Comment?

  5. U.S. stocks rise, extending gains into third dayRead the original story w/Photo

    Wednesday Apr 16 | The Times

    Magic turnaround on Wall Street: Summary: Stocks beat back declines to finish higher in another choppy session with help from Coke, J&J earnings; Yahoo beats after the bell, but Intel results mixed; Twitter flies against troubled time for tech.

    Comment?

  6. J&J stock soars after big profit gainRead the original story

    Wednesday Apr 16 | Hispanic Business

    It helped J&J exceed the predictions of , the company has been trying to regain its position as one of corporate America's most admired companies.

    Comment?

  7. J&J's Q1 profit up 8% on sales jump, lower costsRead the original story

    Wednesday Apr 16 | Modern Healthcare

    A turnaround in Johnson & Johnson's prescription medicine business fueled by new drugs , combined with reduced production and administration expenses, lifted first-quarter profit by 8%.

    Comment?

  8. J&J beats forecasts as sales of new drugs shineRead the original story

    Wednesday Apr 16 | Lincoln Daily News

    J ohnson & Johnson reported quarterly earnings well above expectations, as strong sales of new drugs offset weak demand for consumer products and medical devices, and the company slightly raised its full-year profit view.

    Comment?

  9. Ethicon develops the suture of the future at a 80 million Limerick plantRead the original story w/Photo

    Wednesday Apr 16 | Limerick Today

    A SENIOR executive with Johnson & Johnson has said the local pool of talent and the multinational's positive experience of Limerick were crucial in selecting the city for an Dan Wildman, worldwide president of Ethicon Biosurgery, a J&J company, said that the ... (more)

    Comment?

  10. India Morning Call-Global MarketsRead the original story

    Tuesday Apr 15 | Reuters

    U.S. stocks ended a volatile session higher on Tuesday, lifted by gains in such blue-chip names as Coca-Cola and Johnson & Johnson, though persistent weakness in momentum names limited the Nasdaq's advance.

    Comment?

  11. Magic turnaround on Wall StreetRead the original story

    Tuesday Apr 15 | Reuters

    Up arrows just don't tell the whole story on a day where the Dow bounced between a hundred-point win and a hundred-point loss.

    Comment?

  12. J and J net up 8%Read the original story

    Tuesday Apr 15 | Worcester Telegram & Gazette

    Johnson & Johnson's first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales.

    Comment?

  13. J&J Pharmaceutical Success Drives Increase in 2014 ForecastRead the original story

    Tuesday Apr 15 | The Washington Post

    Johnson & Johnson, the world's biggest maker of health-care products, beat expectations and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices.

    Comment?

  14. Global Markets-Ukraine worries weigh on global shares, drive up bondsRead the original story

    Tuesday Apr 15 | Reuters

    Global equity markets traded flat and government debt rose on Tuesday over rising tensions in Ukraine after Russia declared the country on the brink of civil war, though Wall Street stocks managed to end higher in a volatile session as blue chips advanced.

    Comment?

  15. Will J&J Dump Its Low-Performing Diabetes Device Business?Read the original story w/Photo

    Tuesday Apr 15 | Medical Device/Diagnostic Ind.

    J&J ditched its underperforming Ortho-Clinical Diagnostics unit in March, but diabetes devices are posting even worse sales declines.

    Comment?

  16. Ex J&J exec lands new CEO jobRead the original story

    Tuesday Apr 15 | Retailing Today

    Pacific World Cosmetics has tapped Neutrogena executive Jim Colleran to serve as its new CEO.

    Comment?

  17. Stocks head higher in early trade; J&J gainsRead the original story

    Tuesday Apr 15 | Las Cruces Sun-News

    The Standard & Poor's 500 index rose nine points, or 0.5 percent, to 1,840 in the first few minutes of trading Tuesday.

    Comment?

  18. J&J scoffs at patent cliff amid sales gainRead the original story w/Photo

    Tuesday Apr 15 | MarketWatch

    While the company reported a 3% drop in sales at its consumer products division and no improvement in medical-device revenue, J&J's pharmaceutical sales climbed nearly 11% during the first quarter when compared with the same period in 2013.

    Comment?

  19. J&J raises forecast as demand rises for new psoriasis, schizophrenia, HIV and blood cancer drugsRead the original story

    Tuesday Apr 15 | Dallas Morning News

    Johnson & Johnson, the world's biggest maker of health-care products, raised its 2014 forecast after demand for the company's newest medicines sent first-quarter profit soaring 34 percent.

    Comment?

  20. US stocks open modestly higher; J&J gainsRead the original story

    Tuesday Apr 15 | The New Zealand Herald

    The U.S. stock market opened slightly higher on Tuesday, extending a modest rally as investors weighed a slate of corporate earnings.

    Comment?